Iron is a precious metal in biological terms, having essential roles in oxygen transport, electron transfer and as a cofactor in many enzyme systems, including DNA synthesis. The biological importance of iron is underscored by the evolution of very complex mechanisms for its acquisition, utilisation and preservation in even the most primitive organisms. These systems have evolved because bioavailability of iron is limited and also because its biological activity is potentially toxic as seen, for example, in haemochromatosis. In humans, iron loss from the body is minimall and the level of iron is controlled by regulating its absorption from the intestine.2 3 Iron in food is available in two forns -haem iron (in muscle as myoglobin and haemoglobin) and non-haem iron (in vegetables, cereals and meat). Haem iron accounts for only 10-20% of dietary iron in industrialised countries but can contribute a disproportionate 30% ofthe absorbed iron due to its higher bioavailability. Non-haem iron accounts for 80% of dietary iron in industrialised countries and an even greater proportion worldwide or in vegetarians. 4 For this reason it is more important from a worldwide perspective and it is also more affected by other micronutrients and by regulatory mechanisms in the intestine. 5 Non-haem iron absorption can be considered to occur in two phases-first, the assimilation of iron from the intestinal lumen into the epithelial cell and, second, the transfer or export of the assimilated iron to plasma. Both of these phases are known to be responsive to the level of body iron stores,6 but the intracellular mechanisms influencing these phases and the mechanism by which the enterocyte is informed of body iron requirements are poorly understood.
Here, we draw together evidence from older physiological experiments and more recent studies using cell and molecular biology techniques to the crypts which have a high requirement for iron.2729 The transferrin receptors (TfR) on cell membranes undergo an endocytic cycle during which the pH in the endosome falls as a result of an ATPase mechanism so that iron is released from transferrin to the cell and the endosome with apotransferrin is returned to the cell surface.24 30 Functionally, it is thought that this receptor mechanism cannot operate in reverse to transfer iron to plasma because of the effects of pH on the affinity of transferrin and apotransferrin for endocytic processing.3' The process by which iron is transferred to plasma has been difficult to study and little is known about it. Plasma transferrin does not seem to be necessary for the process as iron absorption is increased when transferrin is deficient or absent,32 and even when present, some iron appears in the portal circulation as non-transferrin bound iron.33 Although not directly involved in iron absorption, it is possible that TfR plays an indirect role by conveying information about body iron stores to the cell.
Influence of information conveyed to crypt cells about body iron stores on the intestine Transferrin receptor is abundantly expressed on all proliferating and growing cells putatively because of their high requirement for iron.26 28 Thus, cells in the crypts of Lieberkuhn always express TfR and the endocytic mechanism may impart information about body iron stores based on plasma transferrin saturation. Transferrin has a single polypeptide chain organised into two domains each with a distinct iron binding site. Studies have shown that diferric transferrin has a much greater affinity for receptormediated endocytosis than monoferric transferrin.27 34 Thus, the rate of delivery of iron to cells improves when body iron stores are increased, transferrin saturation is high and more diferric transferrin is circulating. Consequently, transferrin should be a good candidate for a "humoral" mediator to control iron absorption.35 Several studies have reported the effects of transferrin saturation in relation to iron absorption from the perspective of transferrin accepting iron from intestinal cells.36 None has given sufficient specific information to determine whether transferrin saturation is an important factor in conveying information to the intestine in such a way as to influence iron absorption. Such studies would need to allow for the lag time response in the intestine that may be occasioned by migration of crypt cells to functional sites at the tips of villi. Studies in situations where transferrin is deficient lend support to the proposition that transferrin and its receptor convey information about body iron stores. Atransferrinaemia is a rare congenital condition in which iron absorption is increased and iron overload ensues in a pattern similar to that seen in genetic haemochromatosis.37 A similar condition occurs in the hpx mouse model where hypotransferrinaemia results in iron overload and iron absorption is increased.38 39 This suggests that transferrin is not required for iron transfer to plasma but that it may be essential for conveying the information to enterocytes that body iron stores are replete. If transferrin is given to these patients or mice, there is evidence that iron redistribution can take place, but it is unclear whether iron absorption is controlled in this 40 situation.
Transferrin receptors seem to be regulated in enterocytes29 41 in the same way as in other cells. 42 43 When cells are replete, TfR is down regulated to limit further uptake of plasma iron. Concomitantly, production of ferritin, the iron storage protein, is increased4' and this is known to correlate with iron absorption.44 45 The observation that there is a gradient of TfR expression along the crypt tip-villus axis which apparently mirrors absorptive behaviour25 29 may give a clue to the mechanism by which enterocytes respond to information about body iron stores. To understand how this may occur, some knowledge of cellular iron metabolism is required.
Regulation of the availability of iron Iron in free solution is toxic to biological systems and particularly to membrane structures where it has been implicated in the generation and propagation of free radicals.46 Thus, iron is maintained in a non-toxic form bound to the polymeric protein ferritin. This is a complex protein found in all cells in even the most primitive of organisms and has an enormous capacity to store iron. 47 The ferritin polymer (FN) is made up of 24 subunits composed of either heavy (HF) or light chain (LF) ferritin. In certain tissues or in particular conditions of iron loading, one or other of these subunits may predominate in the FN shell giving rise to a family of isoferritins.47 48There is some evidence that isoferritins have different iron uptake or retaining properties -L-rich ferritin takes up iron more slowly but retains it more avidly than H-rich ferritin.49 H-rich ferritin may have a higher capacity for rapid iron uptake.48 This has given rise to the idea that H-rich ferritin may have a housekeeping function in cells where iron availability is labile, whereas L-rich ferritin primarily has a longer term storage function. The tissue distribution of isoferritin (for example, L-rich in liver; H-rich in heart or reticuloendothelial cells)415' and the ability to change a tissue's isoferritin profile in response to iron excess or deficiency49 52 are consistent with this concept.
L-and H-ferritin are encoded by different genes on separate chromosomes. Their initial transcription is coordinated and the amount of L-and H-ferritin mRNA transcribed may be set constitutively in cells according to the iron milieu in which they find themselves.45 48 49 To respond rapidly to changes in iron availability, a posttranscriptional mechanism has evolved to allow ferritin to become rapidly available without having redundant protein in the cells.53 This means that there is abundant ferritin mRNA in cells, the translation of which is repressed until iron is present. Thus, as cellular iron availability is increased, ferritin synthesis also increases to ensure adequate storage and "detoxifying" capacity in the cell.
The molecular regulation of ferritin expression is elegantly linked to the reciprocal molecular regulation of TfR expression which controls entry of iron from plasma into most cells in the body (Figure) .54 The essence of such control is a sequence of mRNA which folds into a stemloop structure and confers "iron-responsiveness" to protein expression.55 These iron-responsive elements (IREs) interact with a protein (iron-responsive protein; IRP) and can result in repression of mRNA translation by impeding ribosomal attachment or enhance translation by protecting the poly-A tail against degradation according to their position in the RNA transcripts. In the presence of iron the affinity of the IRP for IREs is weakened, leading to down regulation of TfR because its mRNA is degraded and increased ferritin synthesis because "dormant" or repressed ferritin mRNA can now be translated. Other key proteins involved in iron metabolism, such as transferrin and 5'-amino-levulinate synthase, are regulated in a similar way,56 57 and it is possible that membrane proteins involved in iron transport also respond to iron concentrations through control of IREs. This mechanism for controlling iron availability to cells from plasma probably also operates in the intestinal cell where the reciprocal expression of these proteins in relation to body iron load has also been reported.25 29 3. An intracellular iron storage pool exchanges iron as required with other cellular compartments. It is unclear whether iron derivedfrom plasma and from the gut lumen is dealt with in the same way by this pool in enterocytes or whether iron from these pathways is kept separate. Both plasma-derived and diet-derived iron are incorporated into ferritin. 4. The mechanism for iron transfer to plasma is poorly understood. Although transferrin may normally play some role in transporting iron in the portal circulation, it is not essentialfor this process. 5. Iron is taken up by enterocytes from plasma by a receptor-ligand endocytic mechanism. The endosome becomes acidified by an A TPase mechanism, iron is released to the cell and apotransferrin is recycled to the plasma surface. Iron delivery is determined by density of receptor expression and iron saturation ofplasma transferrin. 6. Iron supplied to cells controls the expression ofproteins such as transferrin receptor andferritin. The mRNA for these and some other ironrelated proteins contain a sequence of nucleotides which form a stem-loop structure and confer iron-responsiveness to the translation of the mRNA (thus called iron-responsive elements: IRE) by binding a protein (ironresponsive protein: IRP) which seems to be a cytoplasmic aconitase. 7. The ferritin heteropolymer is composed ofsubunits which have different iron uptake and retaining properties. Thus, the isoferritin produced could play a major role in determining iron availability to the cell and to the transfer/export mechanism on the plasma membrane. 8. Another dimension in the control is the migration of cells from proliferative sites in the crypts to the tips of vili It is conceivable that a constitutive level ofprotein, includingferritin, expression is set by transcriptional means in the crypts and modification of this profile is limited by time and post-transcriptional mechanisms when the cells are in functional positions at the tips of villi.
Control of iron absorption
Since the classic studies of Hahn et altt and Granick59 demonstrated increased iron absorption in anaemia, which is reversible when iron stores are replete, many investigators have attempted to delineate the mechanisms that control iron absorption. The concept that has received most attention over the years is that of "mucosal block" in which intestinal cells had a storage capacity for dietary iron that was transferred to the body according to need. The candidate protein most favoured to achieve this process was ferritin.59 60 When it was shown that ferritin synthesis continued in the intestine even in the presence of iron deficiency,61 62 the prospect of its having a regulatory effect on absorption was largely discounted. However, elucidation of the molecular control of ferritin expression54 may explain why ferritin synthesis occurs even in the presence of an iron deficiency state63 and further consideration of ferritin as the candidate protein in a "mucosal block" or a retentive type mechanism is warranted. There is no direct correlation between iron absorption and serum iron or serum iron proteins although there is good correlation with mucosal iron content and body iron stores.6"6 It is well recognised that acute changes in body iron status, whether overload or deficiency, are not reflected by changes in iron absorption for a period of two to three days. 67 68 This lag response time probably correlates with the migration time for proliferating cells in the crypts of Lieberkuhn to differentiate and migrate into functional positions on the villi.69 Thus, the luminal epithelial cells may be pre-programmed in the crypts to respond to dietary iron challenges. It is possible that some of the pre-programming involves synthesis of proteins that have no function until the cells reach the villus tip. Some of the programming should involve the setting of a constitutive L:H ferritin transcript ratio. Ifbody iron stores are replete and plasma transferrin is saturated, then TfR is down regulated in enterocytes early in their migration up the villi. 29 In crypt cells a constitutive ratio of L:H ferritin transcripts could be set such that when the functional cell is exposed to dietary iron two to three days later, an L-rich isoferritin may be produced49 52 that would retain iron for longer and thereby impede its transfer to plasma. The mucosal iron would be lost when the cell desquamates as proposed by Crosby.60 In an iron deficient state, TfR may be persistently expressed on enterocytes, constitutive ferritin transcription favours a lower L:H ratio and when those cells are challenged with dietary iron, an H-rich ferritin protein is synthesised that can give up iron easily according to need and iron transfer to plasma is less impeded. Functional enterocytes at the tips of villi have only a limited lifespan and the translational response of ferritin according to a pre-set L:H transcript ratio may therefore supersede any de novo transcription of ferritin which may take some hours to peak.70
Two other lines of evidence support such an hypothesis.
INFLAMMATORY DISEASES AND NITRIC OXIDE MECHANISMS
The anaemia of chronic inflammatory disease is characterised by a normocytic, normochromic blood profile with reduced serum iron, reduced erythropoiesis, raised serum ferritin, abundant iron stores in marrow, and reduced iron absorption. Experimental studies have implicated cytokines, especially interleukin 113, tumour necrosis factor a and interferon -y in mediating this response,23 possibly through apoferritin sequestration of iron.7' Evidence is emerging that nitric oxide may play a central role in this process as an end-effector of cytokine activity. Nitric oxide has a strong affinity for iron and interferes with the homeostatic mechanism involving IREs on mRNA sequences,72 resulting in increased expression of TfR and increased ferritin synthesis, thereby distorting the normal reciprocal relation between ferritin and TfR protein expression.73 Thus, ferritin expression in the intestinal mucosa is reversibly increased at a time when iron absorption is known to be reduced,74-76 further suggesting that ferritin is a sump or reservoir controlling iron absorption.
GENETIC HAEMOCHROMATOSIS
In this condition, iron absorption continues at a level inappropriate for the increased amount of body iron stores.6 64 The intestinal L:H ferritin ratio is lower in haemochromatosis than would be expected,45 77 possibly allowing proportionately more iron to transfer to plasma.
The fact that several iron proteinsI9 40 45 and iron uptake mechanisms2 64 78 are demonstrably inappropriate though still all apparently coordinately regulated in the intestine suggests that there is a common regulatory defect. One such example may involve the ATP protein which regulates acidification of endocytic vesicles containing transferrin and its receptor. The specific consequence of a defective endocytic vesicle ATPase in enterocytes, in contrast to other cell types which have altrenative means of importing iron,3' would be to signal an apparent shortage of body iron stores resulting in the observed increased enterocyte expression of iron transport proteins and relatively reduced ferritin synthesis. The physiological result of such a defect would be akin to having no transferrin,37 39 In conclusion, it seems that the mechanisms of assimilating and harnessing iron that have evolved over millions of years in primitive bacterial cells may operate in tandem to control iron absorption in the intestine. The uptake pump has a background activity level which can be increased if more iron is required. A reservoir or sump capacity for iron may reside in the molecular regulation of ferritin which is responsive to body iron stores and can operate to impede iron transfer to plasma. Cytokines and nitric oxide may operate through this system to reduce the availability of iron during inflammation. The three dimensional architecture of the intestinal villus adds a further degree of complexity, perhaps contributing a builtin lag time to achieve steady state control of iron absorption. Recent observations in these areas can be used to reinterpret previous physiological observations and suggest exciting possibilities for further study.
Note added in proof Since this article was written, a Cys-282-Tyr mutation in the HLA H region of chromosome 6 has been discovered in association with genetic haemochromatosis. 84 
